Seth C. Silber is a partner in the firm’s Washington, D.C., office, where he focuses on advising clients in the pharmaceutical and healthcare markets, including issues concerning pharmaceutical patent settlements, mergers and acquisitions, and anticompetitive conduct. He regularly represents clients before both the Federal Trade Commission and U.S. Department of Justice.
Seth joined Wilson Sonsini Goodrich & Rosati in September 2006 after serving for six years at the Federal Trade Commission (FTC). During his tenure at the FTC, Seth obtained unique experience and insights into the commission’s antitrust activities and enforcement practices, having served at all levels of the commission.
From 2004 to 2006, Seth served as an advisor to former FTC Chairman Jon Leibowitz, advising him on enforcement issues relating to both anticompetitive conduct and mergers affecting various industries, including healthcare, medical devices, media, and oil and gas.
He also served as an Assistant to the Bureau Director in the Bureau of Competition. In that role, he reviewed recommendations from the bureau staff on both merger and non-merger matters, with a particular emphasis on pharmaceutical matters.
During his first three years at the FTC, Seth was a staff attorney in the bureau’s Health Care Division. He was a lead attorney in FTC v. Schering-Plough and was involved in many of the commission’s investigations involving pharmaceutical patent settlements and Orange Book listings.
While in the Health Care Division, he also conducted several merger investigations and served as the division’s liaison to the Food and Drug Administration. In his current practice at WSGR, Seth regularly counsels clients regarding the antitrust risks posed by pharmaceutical patent settlements and has represented clients in FTC investigations of such settlements.
He has also served as lead counsel for several cutting-edge pharmaceutical litigations including litigation concerning pharmaceutical product hopping, REMS systems, and standard setting in the pharmaceutical industry.
Seth is active in the American Bar Association’s Antitrust Section. He currently serves as chair of the Health Care and Pharmaceuticals Committee, a position he also held from 2009 to 2012. He was appointed in 2012 to serve on the section’s governing council and is the lead editor of the first-ever treatise on pharmaceutical antitrust, the Pharmaceutical Industry Antitrust Handbook, which was published by the ABA in 2009.
Prior to joining the FTC, Seth was in private practice at Paul Hastings in Washington, D.C. He also is a part-owner and treasurer of the Potomac Nationals, the Class-A minor league baseball affiliate of the Washington Nationals. Additionally, Seth currently serves as the board chair for One World Education, a Washington, D.C.-based nonprofit.
- J.D., George Washington University Law School, 1997
- M.A., Johns Hopkins School of Advanced International Studies (SAIS), 1993
- B.A., Emory University, 1991
ASSOCIATIONS AND MEMBERSHIPS:
- Chair, Health Care and Pharmaceuticals Committee, Section of Antitrust Law, American Bar Association, 2007-2013
- Member, Governing Council, Section of Antitrust Law, American Bar Association (appointed for 2013-2016 term)
- Bar of the District of Columbia
Rate : $$$